Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
[DEF 14A] Milestone Pharmaceuticals Inc. Definitive Proxy Statement
Milestone Pharmaceuticals Inc. has filed its definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Shareholders, to be held virtually on June 10, 2026. Shareholders will vote on the election of eight directors, the ratification of PricewaterhouseCoopers LLP as auditor, an increase of 6,800,000 shares under the 2019 Equity Incentive Plan, and a non-binding advisory vote on executive compensation. The Board recommends voting FOR all proposals, emphasizing strong governance practices and the need for additional shares to attract and retain talent, especially following the FDA approval of CARDAMYST™.